Uncategorized

AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant

Published

on

News of the joint venture comes months after AstraZeneca vowed to spend $15 billion in China by the end of the decade.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version